Lindbrook Capital’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$557K Buy
7,574
+141
+2% +$10.4K 0.05% 209
2024
Q4
$487K Sell
7,433
-456
-6% -$29.9K 0.04% 220
2024
Q3
$615K Sell
7,889
-692
-8% -$53.9K 0.05% 195
2024
Q2
$669K Buy
8,581
+576
+7% +$44.9K 0.06% 170
2024
Q1
$542K Buy
8,005
+137
+2% +$9.28K 0.05% 206
2023
Q4
$530K Buy
7,868
+652
+9% +$43.9K 0.05% 190
2023
Q3
$489K Sell
7,216
-92
-1% -$6.23K 0.05% 184
2023
Q2
$523K Buy
7,308
+98
+1% +$7.01K 0.06% 176
2023
Q1
$500K Buy
7,210
+602
+9% +$41.8K 0.06% 172
2022
Q4
$448K Buy
6,608
+280
+4% +$19K 0.06% 196
2022
Q3
$347K Buy
6,328
+211
+3% +$11.6K 0.06% 192
2022
Q2
$404K Buy
6,117
+970
+19% +$64.1K 0.07% 174
2022
Q1
$341K Buy
5,147
+74
+1% +$4.9K 0.05% 206
2021
Q4
$296K Sell
5,073
-28
-0.5% -$1.63K 0.05% 233
2021
Q3
$306K Buy
5,101
+517
+11% +$31K 0.08% 103
2021
Q2
$275K Buy
4,584
+132
+3% +$7.92K 0.06% 131
2021
Q1
$221K Buy
4,452
+138
+3% +$6.85K 0.05% 142
2020
Q4
$216K Sell
4,314
-112
-3% -$5.61K 0.05% 131
2020
Q3
$243K Buy
4,426
+250
+6% +$13.7K 0.07% 110
2020
Q2
$221K Buy
4,176
+494
+13% +$26.1K 0.07% 108
2020
Q1
$164K Sell
3,682
-806
-18% -$35.9K 0.06% 119
2019
Q4
$224K Buy
4,488
+96
+2% +$4.79K 0.08% 126
2019
Q3
$196K Sell
4,392
-60
-1% -$2.68K 0.07% 137
2019
Q2
$183K Buy
4,452
+191
+4% +$7.85K 0.07% 141
2019
Q1
$172K Sell
4,261
-28
-0.7% -$1.13K 0.07% 142
2018
Q4
$162K Buy
+4,289
New +$162K 0.08% 132